- Home
- SLMBP vs BSX Comparison
SLMBP vs BSX Comparison
Compare SLMBP & BSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SLMBP | BSX |
|---|---|---|
| Founded | N/A | 1979 |
| Country | United States | United States |
| Employees | 1710 | N/A |
| Industry | Finance: Consumer Services | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | N/A | 149.7B |
| IPO Year | N/A | 1992 |
Fundamental Metrics
Financial Performance| Metric | SLMBP | BSX |
|---|---|---|
| Price | $74.85 | $91.92 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 18 |
| Target Price | N/A | ★ $125.33 |
| AVG Volume (30 Days) | N/A | ★ 9.8M |
| Earning Date | N/A | 02-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 54.68 |
| EPS | N/A | ★ 1.87 |
| Revenue | N/A | ★ $19,349,000,000.00 |
| Revenue This Year | N/A | $21.05 |
| Revenue Next Year | N/A | $11.43 |
| P/E Ratio | ★ N/A | $49.51 |
| Revenue Growth | N/A | ★ 21.61 |
| 52 Week Low | N/A | $85.98 |
| 52 Week High | N/A | $109.50 |
Technical Indicators
Market Signals| Indicator | SLMBP | BSX |
|---|---|---|
| Relative Strength Index (RSI) | 49.18 | 32.14 |
| Support Level | $70.58 | $91.45 |
| Resistance Level | $75.74 | $93.89 |
| Average True Range (ATR) | 0.80 | 2.05 |
| MACD | 0.09 | -0.77 |
| Stochastic Oscillator | 82.76 | 5.07 |
Price Performance
Historical ComparisonAbout SLMBP SLM Corporation Floating Rate Non-Cumulative Preferred Stock Series B
SLM Corp is an education solutions company. It business is to originate and service loans to students and their families to finance the cost of their education. The provide Private Education Loans to mean education loans to students or their families that are not made, insured, or guaranteed by any state or federal government.
About BSX Boston Scientific Corporation
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.